"While it is an intriguing business opportunity, it is not without risks since it isn't cheap to become a manufacturer and generic competition is harsh," says Scott Knoer, Cleveland Clinic's chief pharmacy officer.
from Kaiser Health News http://ift.tt/2DREt60
0 comments:
Post a Comment